A cell culture/biotech company making strides in enhancing organ preservation and cell culturing at both room temperature and through cryopreservation. The LIFOR® technology is the nanoparticle component of the solution, which carries the oxygen or any type of drug or nutrient that the developers wish to place into the nanoparticle.
LightSmyth develops innovative nanophotonic products. Target areas include integrated photonics, free-space diffractives, and consumer products. LightSmyth products and innovations are centered around application of holographic and diffractive principles combined with manufacturing via state-of-the-art semiconductor patterning tools such as Deep UltraViolet (DUV) steppers/scanners.
The company is developing a new generation of advanced nonlinear electro-optic and all-optical organic polymers that can convert high-speed electronic signals into optical signals or allow light waves to switch other light waves.
Magnolia Solar is seeking to commercialize its nanotechnology-based, high efficiency, thin film technology that can be deposited on glass and other flexible structures. This technology has the ability to capture a larger part of the solar spectrum to produce high efficiency solar cells, and incorporates a unique nanostructure-based antireflection coating technology to further increase the solar cell's efficiency, thereby reducing the cost per watt.
The company offers high-quality in house manufacturing of monodispersed polystyrene latex particles, also known as uniform latex particles, latex nanoparticles, and monosized latex particles to the medical and scientific communities.
The company is focused on realizing the potential of RNAi-based therapeutics through the development of a broad-based, state-of-the-art drug discovery platform built upon industry leading expertise in RNA chemistry and oligonucleotide delivery.